Ling Lu
Impact in
-
- Sirtuins and Resveratrol in Medicine
Papers in
-
- Angiogenesis and VEGF in Cancer 3
-
- Liver Disease Diagnosis and Treatment 2
- Co-authors
- Kuan-Boone Tan (1 shared paper)Hao Daniel Lin (1 shared paper)Gigi N.C. Chiu (1 shared paper)Pengyuan Yang (5 shared papers)Yao‐Cheng Rui (5 shared papers)Hui Kang (3 shared papers)Tiejun Li (3 shared papers)Lan Chen (1 shared paper)
In The Last Decade
Ling Lu
17 papers receiving 351 citations
Peers
Comparison fields: 5 of 85
- Geriatrics and Gerontology 16
- Pharmacology 26
- Cancer Research 41
- Complementary and alternative medicine 21
- Molecular Biology 167
Countries citing papers authored by Ling Lu
This map shows the geographic impact of Ling Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Lu more than expected).
Fields of papers citing papers by Ling Lu
This network shows the impact of papers produced by Ling Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Lu. The network helps show where Ling Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ling Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 126 | |
| 2 | 2005 | 53 | |
| 3 | 2018 | 39 | |
| 4 | 2007 | 26 | |
| 5 | 2021 | 24 | |
| 6 | 2009 | 20 | |
| 7 | 2006 | 15 | |
| 8 | 2018 | 15 | |
| 9 | 2005 | 10 | |
| 10 | 2024 | 8 | |
| 11 | 2014 | 7 | |
| 12 | 2023 | 3 | |
| 13 | 2020 | 3 | |
| 14 | 2020 | 3 | |
| 15 | 2019 | 2 | |
| 16 | 2020 | 2 | |
| 17 | 2016 | 1 |
About Ling Lu
Ling Lu is a scholar working on Molecular Biology, Epidemiology, Physiology, Immunology and Infectious Diseases, having authored 17 papers that have together received 357 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (3 papers), Angiogenesis and VEGF in Cancer (3 papers), COVID-19 Clinical Research Studies (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Lipid metabolism and disorders (2 papers), IL-33, ST2, and ILC Pathways (2 papers), Organ Transplantation Techniques and Outcomes (2 papers) and Liver Disease and Transplantation (2 papers). The work is most often cited by research in Geriatrics and Gerontology (16 citations), Pharmacology (26 citations), Cancer Research (41 citations), Complementary and alternative medicine (21 citations) and Molecular Biology (167 citations). Ling Lu has collaborated with scholars based in China, Iran and Singapore. Frequent co-authors include Kuan-Boone Tan, Hao Daniel Lin, Gigi N.C. Chiu, Pengyuan Yang, Yao‐Cheng Rui, Hui Kang, Tiejun Li, Lan Chen, Wen Li and Daoxin Wang. Their work appears in journals such as Life Sciences, Journal of Pharmacological Sciences, Transplantation, BioMed Research International and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.